Risk.net

A View on 2007: By Morrison & Foerster's Anna Pinedo

What will 2007 hold for structured products regulation? Continuing our series of thoughts on the year ahead Structured Products invited Anna Pinedo, partner at US law firm Morrison & Foerster in New York, to provide her thoughts on the subject.

  • LinkedIn  
  • Save this article
  • Print this page  

As the market for structured products grows beyond institutional investors and the volume of structured product issuances continues to increase, structured products attract more attention in the mainstream and business press. Articles commenting on structured products refer to them as the “quirkiest vehicles on the Street” (to quote Business Week) or “arcane investments” (to quote The Wall Street Journal). Meanwhile, a greater percentage of these products are directed to retail investors.

We

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Copyright Infopro Digital Limited. All rights reserved.

As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.

If you would like to purchase additional rights please email info@risk.net

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.

If you would like to purchase additional rights please email info@risk.net

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

More on Exchange-traded products

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here